We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Neuropsychiatric Assessment Aids Move to Class II/Special Controls
Neuropsychiatric Assessment Aids Move to Class II/Special Controls
Neuropsychiatric interpretive EEG assessment aids should undergo clinical performance testing to demonstrate the accuracy, precision and reproducibility of results, including any specified cutoffs, the FDA says.